Moors & Cabot’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.65M Sell
42,818
-258
-0.6% -$23K 0.16% 138
2025
Q4
$3.4M Sell
43,076
-2,919
-6% -$229K 0.15% 139
2025
Q3
$3.68M Sell
45,995
-3,869
-8% -$330K 0.16% 124
2025
Q2
$4.53M Buy
49,864
+2,251
+5% +$205K 0.21% 97
2025
Q1
$4.46M Buy
47,613
+97
+0.2% +$8.69K 0.23% 95
2024
Q4
$4.32M Buy
47,516
+2,081
+5% +$199K 0.21% 97
2024
Q3
$4.72M Sell
45,435
-1,087
-2% -$111K 0.23% 88
2024
Q2
$4.51M Buy
46,522
+2,137
+5% +$197K 0.24% 90
2024
Q1
$4M Buy
44,385
+3
+0% +$254 0.22% 98
2023
Q4
$3.54M Buy
44,382
+2,073
+5% +$156K 0.22% 104
2023
Q3
$3.01M Sell
42,309
-102
-0.2% -$7.63K 0.2% 108
2023
Q2
$3.27M Sell
42,411
-25
-0.1% -$1.94K 0.22% 107
2023
Q1
$3.19M Sell
42,436
-455
-1% -$33.8K 0.22% 110
2022
Q4
$3.38M Sell
42,891
-377
-0.9% -$28.3K 0.24% 98
2022
Q3
$3.04M Sell
43,268
-1,149
-3% -$90.1K 0.23% 95
2022
Q2
$3.56M Sell
44,417
-648
-1% -$50.7K 0.26% 91
2022
Q1
$3.42M Buy
45,065
+587
+1% +$46.5K 0.21% 106
2021
Q4
$3.8M Sell
44,478
-2,881
-6% -$225K 0.23% 93
2021
Q3
$3.58M Sell
47,359
-922
-2% -$73.2K 0.23% 99
2021
Q2
$3.93M Buy
48,281
+1,108
+2% +$90.6K 0.28% 83
2021
Q1
$3.72M Buy
47,173
+376
+0.8% +$29.5K 0.28% 82
2020
Q4
$4M Sell
46,797
-4,326
-8% -$358K 0.34% 70
2020
Q3
$3.94M Sell
51,123
-3,925
-7% -$299K 0.37% 64
2020
Q2
$4.04M Buy
55,048
+15,793
+40% +$1.12M 0.43% 55
2020
Q1
$2.61M Sell
39,255
-17,154
-30% -$1.21M 0.38% 66
2019
Q4
$3.88M Buy
56,409
+2,250
+4% +$153K 0.39% 62
2019
Q3
$3.98M Buy
54,159
+2,319
+4% +$168K 0.44% 57
2019
Q2
$3.72M Buy
51,840
+3,008
+6% +$214K 0.47% 52
2019
Q1
$3.34M Sell
48,832
-4,942
-9% -$319K 0.45% 55
2018
Q4
$3.21M Sell
53,774
-2,966
-5% -$186K 0.5% 46
2018
Q3
$3.8M Sell
56,740
-1,491
-3% -$99.3K 0.46% 52
2018
Q2
$3.78M Sell
58,231
-6,724
-10% -$440K 0.51% 48
2018
Q1
$4.66M Sell
64,955
-99
-0.2% -$7.12K 0.62% 30
2017
Q4
$4.91M Buy
65,054
+1,950
+3% +$142K 0.65% 30
2017
Q3
$4.59M Buy
63,104
+4,464
+8% +$322K 0.66% 27
2017
Q2
$4.34M Sell
58,640
-987
-2% -$73.3K 0.72% 23
2017
Q1
$4.36M Sell
59,627
-1,444
-2% -$101K 0.74% 24
2016
Q4
$4M Buy
61,071
+1,261
+2% +$86.5K 0.66% 28
2016
Q3
$4.43M Buy
59,810
+2,757
+5% +$204K 0.74% 23
2016
Q2
$4.17M Sell
57,053
-9,095
-14% -$648K 0.73% 24
2016
Q1
$4.67M Sell
66,148
-218
-0.3% -$14.5K 0.84% 18
2015
Q4
$4.43M Sell
66,366
-1,515
-2% -$101K 0.81% 17
2015
Q3
$4.31M Sell
67,881
-475
-0.7% -$31K 0.8% 19
2015
Q2
$4.47M Buy
68,356
+2,333
+4% +$158K 0.73% 27
2015
Q1
$4.58M Sell
66,023
-245
-0.4% -$16.9K 0.76% 24
2014
Q4
$4.59M Sell
66,268
-938
-1% -$63.3K 0.78% 23
2014
Q3
$4.39M Buy
67,206
+360
+0.5% +$23.7K 0.75% 25
2014
Q2
$4.57M Buy
66,846
+6,738
+11% +$452K 0.77% 27
2014
Q1
$3.9M Buy
+60,108
New +$3.79M 0.99% 18

Other funds holding CL

Moors & Cabot's CL Position: Q1 2026 in Review

Moors & Cabot reduced its Colgate-Palmolive (CL) stake by 0.6% in Q1 2026, selling an estimated $23K and leaving 42,818 shares worth $3.65M. The position accounts for 0.16% of the portfolio, ranked #138.

Moors & Cabot first reported a position in CL in Q1 2014 and has held it in 49 quarters since. The position peaked at $4.91M in Q4 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Moors & Cabot held 42,818 shares of Colgate-Palmolive worth $3.65M as of Q1 2026.
  • Moors & Cabot sold 258 Colgate-Palmolive shares in Q1 2026, an estimated $23K.
  • Colgate-Palmolive made up 0.16% of Moors & Cabot's portfolio in Q1 2026, its #138 holding.
  • Moors & Cabot first reported a position in Colgate-Palmolive in Q1 2014 and has held it in 49 quarters since.
  • Moors & Cabot's Colgate-Palmolive position peaked at $4.91M in Q4 2017.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.